Patient and public involvement in mobile health-based research for hay fever: a qualitative study of patient and public involvement implementation process.
Allergic conjunctivitis
Allergic rhinitis
Hay fever
Mobile health
Patient and public engagement
Patient and public involvement
Pollinosis
Public engagement
ResearchKit
Smartphone application
Journal
Research involvement and engagement
ISSN: 2056-7529
Titre abrégé: Res Involv Engagem
Pays: England
ID NLM: 101708164
Informations de publication
Date de publication:
02 Sep 2022
02 Sep 2022
Historique:
received:
11
03
2022
accepted:
29
08
2022
entrez:
2
9
2022
pubmed:
3
9
2022
medline:
3
9
2022
Statut:
epublish
Résumé
Smartphones are being increasingly used for research owing to their multifunctionality and flexibility, and crowdsourced research using smartphone applications (apps) is effective in the early detection and management of chronic diseases. We developed the AllerSearch app to gather real-world data on individual subjective symptoms and lifestyle factors related to hay fever. This study established a foundation for interactive research by adopting novel, diverse perspectives accrued through implementing the principles of patient and public involvement (PPI) in the development of our app. Patients and members of the public with a history or family history of hay fever were recruited from November 2019 to December 2021 through a dedicated website, social networking services, and web briefing according to the PPI Guidebook 2019 by the Japan Agency for Medical Research and Development. Nine opinion exchange meetings were held from February 2020 to December 2021 to collect opinions and suggestions for updating the app. After each meeting, interactive evaluations from PPI contributors and researchers were collected. The compiled suggestions were then incorporated into the app, establishing an active feedback loop fed by the consistently interactive infrastructure. Four PPI contributors (one man and three women) were recruited, and 93 items were added/changed in the in-app survey questionnaire in accordance with discussions from the exchange meetings. The exchange meetings emphasized an atmosphere and opportunity for participants to speak up, ensuring frequent opportunities for them to contribute to the research. In March 2020, a public website was created to display real-time outcomes of the number of participants and users' hay-fever-preventative behaviors. In August 2020, a new PPI-implemented AllerSearch app was released. This study marks the first research on clinical smartphone apps for hay fever in Japan that implements PPI throughout its timeline from research and development to the publication of research results. Taking advantage of the distinct perspectives offered by PPI contributors, a step was taken toward actualizing a foundation for an interactive research environment. These results should promote future PPI research and foster the establishment of a social construct that enables PPI efforts in various fields. Patient and public involvement (PPI) plays an important role in promoting effective execution of health science research, as well as in the establishment of a social agreement and infrastructure for the care of various diseases, including cancer, chronic diseases, and allergic illnesses. Hay fever is one of the most common allergic diseases, affecting more than 30 million people in Japan. It is known for its myriad factors and diverse presentations. Previously, we developed a mobile health (mHealth) smartphone application (app) for hay fever—AllerSearch—released in February 2018. This app is capable of collecting relevant digital phenotypes and user-provided information, which are used in providing tailored, evidence-based suggestions. To our knowledge, no other studies have been conducted on the implementation of PPI in mHealth. Since hay fever presents with a wide variety of symptoms and risk factors, PPI principles appear well-suited for eliciting insights from the patient/public population and for incorporating new, expert perspectives into the research process. In this study, we included PPI contributors in the research plan, app development, and evaluation. Most notably, the survey questionnaire and user interface of the app was tailored based on PPI feedback. The updated AllerSearch app was released during this study period. Since hay fever is a widespread and variable illness, the multifaceted input from patients and public experts enabled by PPI implementation holds promise for improving society-wide healthcare and in empowering a culture toward medical involvement.
Sections du résumé
BACKGROUND
BACKGROUND
Smartphones are being increasingly used for research owing to their multifunctionality and flexibility, and crowdsourced research using smartphone applications (apps) is effective in the early detection and management of chronic diseases. We developed the AllerSearch app to gather real-world data on individual subjective symptoms and lifestyle factors related to hay fever. This study established a foundation for interactive research by adopting novel, diverse perspectives accrued through implementing the principles of patient and public involvement (PPI) in the development of our app.
METHODS
METHODS
Patients and members of the public with a history or family history of hay fever were recruited from November 2019 to December 2021 through a dedicated website, social networking services, and web briefing according to the PPI Guidebook 2019 by the Japan Agency for Medical Research and Development. Nine opinion exchange meetings were held from February 2020 to December 2021 to collect opinions and suggestions for updating the app. After each meeting, interactive evaluations from PPI contributors and researchers were collected. The compiled suggestions were then incorporated into the app, establishing an active feedback loop fed by the consistently interactive infrastructure.
RESULTS
RESULTS
Four PPI contributors (one man and three women) were recruited, and 93 items were added/changed in the in-app survey questionnaire in accordance with discussions from the exchange meetings. The exchange meetings emphasized an atmosphere and opportunity for participants to speak up, ensuring frequent opportunities for them to contribute to the research. In March 2020, a public website was created to display real-time outcomes of the number of participants and users' hay-fever-preventative behaviors. In August 2020, a new PPI-implemented AllerSearch app was released.
CONCLUSIONS
CONCLUSIONS
This study marks the first research on clinical smartphone apps for hay fever in Japan that implements PPI throughout its timeline from research and development to the publication of research results. Taking advantage of the distinct perspectives offered by PPI contributors, a step was taken toward actualizing a foundation for an interactive research environment. These results should promote future PPI research and foster the establishment of a social construct that enables PPI efforts in various fields.
Patient and public involvement (PPI) plays an important role in promoting effective execution of health science research, as well as in the establishment of a social agreement and infrastructure for the care of various diseases, including cancer, chronic diseases, and allergic illnesses. Hay fever is one of the most common allergic diseases, affecting more than 30 million people in Japan. It is known for its myriad factors and diverse presentations. Previously, we developed a mobile health (mHealth) smartphone application (app) for hay fever—AllerSearch—released in February 2018. This app is capable of collecting relevant digital phenotypes and user-provided information, which are used in providing tailored, evidence-based suggestions. To our knowledge, no other studies have been conducted on the implementation of PPI in mHealth. Since hay fever presents with a wide variety of symptoms and risk factors, PPI principles appear well-suited for eliciting insights from the patient/public population and for incorporating new, expert perspectives into the research process. In this study, we included PPI contributors in the research plan, app development, and evaluation. Most notably, the survey questionnaire and user interface of the app was tailored based on PPI feedback. The updated AllerSearch app was released during this study period. Since hay fever is a widespread and variable illness, the multifaceted input from patients and public experts enabled by PPI implementation holds promise for improving society-wide healthcare and in empowering a culture toward medical involvement.
Autres résumés
Type: plain-language-summary
(eng)
Patient and public involvement (PPI) plays an important role in promoting effective execution of health science research, as well as in the establishment of a social agreement and infrastructure for the care of various diseases, including cancer, chronic diseases, and allergic illnesses. Hay fever is one of the most common allergic diseases, affecting more than 30 million people in Japan. It is known for its myriad factors and diverse presentations. Previously, we developed a mobile health (mHealth) smartphone application (app) for hay fever—AllerSearch—released in February 2018. This app is capable of collecting relevant digital phenotypes and user-provided information, which are used in providing tailored, evidence-based suggestions. To our knowledge, no other studies have been conducted on the implementation of PPI in mHealth. Since hay fever presents with a wide variety of symptoms and risk factors, PPI principles appear well-suited for eliciting insights from the patient/public population and for incorporating new, expert perspectives into the research process. In this study, we included PPI contributors in the research plan, app development, and evaluation. Most notably, the survey questionnaire and user interface of the app was tailored based on PPI feedback. The updated AllerSearch app was released during this study period. Since hay fever is a widespread and variable illness, the multifaceted input from patients and public experts enabled by PPI implementation holds promise for improving society-wide healthcare and in empowering a culture toward medical involvement.
Identifiants
pubmed: 36056430
doi: 10.1186/s40900-022-00382-6
pii: 10.1186/s40900-022-00382-6
pmc: PMC9437402
doi:
Types de publication
Journal Article
Langues
eng
Pagination
45Subventions
Organisme : Japan Agency for Medical Research and Development
ID : 21ek0410063
Informations de copyright
© 2022. The Author(s).
Références
Recent Pat Inflamm Allergy Drug Discov. 2009 Jun;3(2):118-27
pubmed: 19519588
J Diabetes Sci Technol. 2018 May;12(3):577-586
pubmed: 29635931
JMIR Form Res. 2022 Aug 23;6(8):e38475
pubmed: 35998022
Emerg Med J. 2016 Sep;33(9):665-70
pubmed: 27044949
J Clin Med. 2022 May 24;11(11):
pubmed: 35683352
Arerugi. 2014 Jun;63(6):764-6
pubmed: 24953735
Allergy Asthma Proc. 1997 Mar-Apr;18(2):63-7
pubmed: 9134061
Ann Allergy Asthma Immunol. 2003 Sep;91(3):288-96
pubmed: 14533662
J Med Internet Res. 2020 Jun 26;22(6):e18996
pubmed: 32589162
Ophthalmology. 2019 May;126(5):766-768
pubmed: 30550734
NPJ Digit Med. 2021 Dec 20;4(1):171
pubmed: 34931013
Allergol Int. 2022 Jul;71(3):325-334
pubmed: 35105520
Ocul Surf. 2022 Jul;25:19-25
pubmed: 35483601
J Comp Eff Res. 2015 Mar;4(2):133-45
pubmed: 25825842
Health Policy. 2021 Sep;125(9):1208-1221
pubmed: 34376328
NPJ Digit Med. 2019 Sep 6;2:88
pubmed: 31508498
Cornea. 2020 Nov;39 Suppl 1:S39-S46
pubmed: 33055549
J Allergy Clin Immunol. 2001 Jul;108(1 Suppl):S2-8
pubmed: 11449200
Disabil Rehabil. 2015;37(15):1390-400
pubmed: 25243763
Palliat Med. 2019 Sep;33(8):969-984
pubmed: 31250702
Res Involv Engagem. 2020 Oct 27;6:63
pubmed: 33133636
J Cataract Refract Surg. 2012 Jun;38(6):1028-33
pubmed: 22624902
Prim Health Care Res Dev. 2016 Nov;17(6):536-548
pubmed: 26856306
BMJ. 2018 Dec 6;363:k5147
pubmed: 30522999
Int J Technol Assess Health Care. 2011 Oct;27(4):391-9
pubmed: 22004782
Curr Opin Allergy Clin Immunol. 2011 Oct;11(5):477-82
pubmed: 21822130
Health Expect. 2021 May;24 Suppl 1:47-53
pubmed: 31808266
Health Expect. 2017 Aug;20(4):543-554
pubmed: 27516003
JAMA. 2017 Oct 3;318(13):1215-1216
pubmed: 28973224
Clin Exp Allergy. 2004 Apr;34(4):520-6
pubmed: 15080802
Allergy. 2021 Dec;76(12):3820-3824
pubmed: 34480802
Arerugi. 2003 Jul;52 Suppl 1:70-86
pubmed: 14679650
BMJ. 2018 Nov 28;363:k4738
pubmed: 30487232
Health Expect. 2014 Oct;17(5):637-50
pubmed: 22809132
Arerugi. 2017;66(2):120-121
pubmed: 28331105
Res Involv Engagem. 2020 Apr 17;6:13
pubmed: 32322408
Arerugi. 2020;69(1):23-33
pubmed: 32051366
J Allergy Clin Immunol. 2003 Jun;111(6):1232-8
pubmed: 12789222
J Med Ethics. 2018 Dec;44(12):801-804
pubmed: 30337451
Allergol Int. 2020 Oct;69(4):510-518
pubmed: 32651122
JAMA Ophthalmol. 2020 Jan 1;138(1):58-68
pubmed: 31774457
Jpn J Ophthalmol. 2021 Mar;65(2):271-281
pubmed: 33411099
Medicina (Kaunas). 2021 Apr 14;57(4):
pubmed: 33919683
J R Soc Med. 2009 Oct;102(10):431-42
pubmed: 19797601